Results 111 to 120 of about 1,971,957 (315)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

MULTIFUNCTIONAL AGRICULTURE AS AN INNOVATION PATH FOR RURAL AREAS [PDF]

open access: yes
The main purpose of this paper is to discuss the potential of MFA model to enhance innovation in rural areas build on the analysis of information from a database of best practices on innovation in EU rural areas collected by the RAPIDO project1.
Costa, Susete, Madureira, Livia
core   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

LEGAL SUPPORT TO INNOVATIVE ACTIVITIES [PDF]

open access: yesЭкономика региона, 2009
The whole system of economy regulation, all the institutes of economic law, especially those which regulate investment activity should promote innovative activities. The economic policy and legislation that provides it should be stable enough.
openaire   +1 more source

Do only big cities innovate? : technological maturity and the location of innovation [PDF]

open access: yes
Innovation enhances economic performance. High rates of innovation are associated with high rates of productivity growth, and faster productivity growth leads to higher real wages and improvements in standards of living.
Michael J. Orlando, Michael Verba
core  

Tumor mutational burden as a determinant of metastatic dissemination patterns

open access: yesMolecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal   +4 more
wiley   +1 more source

Innovative strategies for active learning

open access: yesÎnvăţare activă pentru dezvoltare durabilă : Conferinţă ştiinţifică internaţională : Eveniment online, 15 noiembrie 2024 = Active learning for sustainable development : International Scientific Conference : Online event, November 15, 2024 : Conference proceedings
In a modern educational context, active learning has become a central element in the development of critical skills necessary to adapt to the dynamics of the labor market and a knowledge-based society. This article explores various innovative strategies in active learning, such as problem-based learning (PBL), project-based learning (PjBL ...
openaire   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

open access: yesMolecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Home - About - Disclaimer - Privacy